Page last updated: 2024-08-18

pyrazolanthrone and Oral Submucous Fibrosis

pyrazolanthrone has been researched along with Oral Submucous Fibrosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, JZ; Chen, HM; Hsieh, YP; Lin, HY; Yang, H1
Chen, HM; Cheng, SJ; Chiang, CP; Deng, YT; Kuo, MY1
Chang, JZ; Chen, HM; Deng, YT; Kuo, MY; Yang, WH1

Other Studies

3 other study(ies) available for pyrazolanthrone and Oral Submucous Fibrosis

ArticleYear
Epigallocatechin-3-gallate inhibits transforming-growth-factor-β1-induced collagen synthesis by suppressing early growth response-1 in human buccal mucosal fibroblasts.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2017, Volume: 116, Issue:2

    Topics: Anthracenes; Benzamides; Catechin; Cells, Cultured; Collagen Type I; Dioxoles; Early Growth Response Protein 1; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Flavonoids; Humans; Mouth Mucosa; Oral Submucous Fibrosis; Signal Transduction; Transforming Growth Factor beta1

2017
Arecoline-stimulated connective tissue growth factor production in human buccal mucosal fibroblasts: Modulation by curcumin.
    Oral oncology, 2009, Volume: 45, Issue:9

    Topics: Anthracenes; Anti-Inflammatory Agents, Non-Steroidal; Arecoline; Cheek; Cholinergic Agonists; Connective Tissue Growth Factor; Curcumin; Endothelial Cells; Epithelial Cells; Fibroblasts; Flavonoids; Humans; Imidazoles; Mouth Mucosa; Nitriles; Oral Submucous Fibrosis; Pyridines; Sulfones

2009
EGCG blocks TGFβ1-induced CCN2 by suppressing JNK and p38 in buccal fibroblasts.
    Clinical oral investigations, 2013, Volume: 17, Issue:2

    Topics: Anthracenes; Benzamides; Catechin; Cell Line; Cells, Cultured; Connective Tissue Growth Factor; Dinoprostone; Dioxoles; Dose-Response Relationship, Drug; Fibroblasts; Flavonoids; Humans; Imidazoles; Lung; MAP Kinase Kinase 4; Mouth Mucosa; Oral Submucous Fibrosis; p38 Mitogen-Activated Protein Kinases; Protease Inhibitors; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyridines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta1

2013